Drug recall · February 18, 2026
Doxazosin Tablets recall
Why: Tablets/Capsules Imprinted with Wrong ID
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.
- Lots / codes
Lot # GDSH25006, Exp Date: 08/2027
- Quantity
- 60,000 tablets
- Company
- Unichem Pharmaceuticals USA Inc., East Brunswick, NJ
- Distribution
- Nationwide
- Initiated
- January 21, 2026 · Voluntary: Firm initiated
- Classified
- February 11, 2026
- Reported
- February 18, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Doxazosin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.